News

Under the licensing agreement, Tracon will develop and manage clinical trials of Methoxyamine. Methoxyamine was developed by University Hospitals Case Medical Center researchers. Research for this new therapeutic

Total revenue for 2006 from sales of Keflex products is now expected to be approximately $7 million to $10 million, down from prior expectations of $16 million to

The phase I study will be conducted in Uganda and is designed to test the safety of injecting newborns with the vaccine, formally known as ALVAC-HIV. Researchers estimate

The drug has also been granted fast track designation by the Food and Drug Administration. Fast track is a program designed to facilitate the development of new drugs

The phase III trial will evaluate the efficacy of Saforis Powder in UpTec for oral suspension. “Based upon the FDA’s request, we will be evaluating options to maximize

The company will now operate as part of a newly created wholly owned subsidiary of Endo Pharmaceuticals. The transaction includes an up-front payment of up to $20 million,

Boehringer Ingelheim’s acquisition of Zantac will improve the company’s market presence in over-the-counter (OTC) products and could strengthen its presence in the US market. Zantac is regarded as

Nexium, a proton pump inhibitor, is already is indicated for the treatment of gastroesophageal reflux disease and heartburn. Nexium is also is used to reduce the risk of

The approval is a special protocol agreement between Avax and the FDA regarding the trial design and surrogate endpoints to be used as a basis of filing for